Neurobiology of Aging
Volume 30, Issue 8 , Pages 1265-1271 , August 2009

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies

  • Fredrik Boström

      Affiliations

    • Clinical Memory Research Unit, Department of Clinical Sciences, University Hospital MAS 205 02 Malmö, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 40 33 50 36; fax: +46 40 3333 56 54.
    • ,
  • Oskar Hansson

      Affiliations

    • Clinical Memory Research Unit, Department of Clinical Sciences, University Hospital MAS 205 02 Malmö, Sweden
    • ,
  • Lars Gerhardsson

      Affiliations

    • Occupational and Environmental Medicine, Sahlgrenska Academy and University Hospital, Box 414, SE-405 30 Goteborg, Sweden
    • ,
  • Thomas Lundh

      Affiliations

    • Department of Occupational and Environmental Medicine, University Hospital, 222 41 Lund, Sweden
    • ,
  • Lennart Minthon

      Affiliations

    • Clinical Memory Research Unit, Department of Clinical Sciences, University Hospital MAS 205 02 Malmö, Sweden
    • ,
  • Erik Stomrud

      Affiliations

    • Clinical Memory Research Unit, Department of Clinical Sciences, University Hospital MAS 205 02 Malmö, Sweden
    • ,
  • Henrik Zetterberg

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at Göteborg University, S-431 80 Mölndal, Sweden
    • ,
  • Elisabet Londos

      Affiliations

    • Clinical Memory Research Unit, Department of Clinical Sciences, University Hospital MAS 205 02 Malmö, Sweden

Received 15 June 2007 ,Revised 3 October 2007 ,Accepted 29 October 2007.

References 

  1. Adamczyk A, Strosznajder JB. Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels. Neuroreport. 2006;17(18):1883–1886
  2. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 1998;152(4):879–884
  3. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural. Transm. Park. Dis. Dement. Sect. 1991;3(4):231–258
  4. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368(9533):387–403
  5. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001;64(6):575–611
  6. Forte G, Bocca B, Senofonte O, Petrucci F, Brusa L, Stanzione P, et al. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J. Neural. Transm. 2004;111(8):1031–1040
  7. Frolich L, Kornhuber J, Ihl R, Fritze J, Maurer K, Riederer P. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur. Arch. Psychiatry Clin. Neurosci. 1991;240(6):363–366
  8. Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 2006;106(6):1995–2044
  9. Gomez-Tortosa E, Sanders JL, Newell K, Hyman BT. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies. Acta Neuropathol. 2001;101(1):36–42
  10. Jimenez-Jimenez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, et al. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. J. Neural. Transm. 1998;105(4–5):497–505
  11. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 2002;322(5):1089–1102
  12. Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci. 2004;13(12):3245–3252
  13. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998;158(1):47–52
  14. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. For the Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–1872
  15. McKeith IGD, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944
  17. Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, et al. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural. Transm. 1998;105(4–5):479–488
  18. Morgan C, Colombres M, Nunez MT, Inestrosa NC. Structure and function of amyloid in Alzheimer's disease. Prog. Neurobiol. 2004;74(6):323–349
  19. Nielsen MS, Vorum H, Lindersson E, Jensen PH. Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 2001;276(25):22680–22684
  20. Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 2005;14(24):3801–3811
  21. Tamamizu-Kato S, Kosaraju MG, Kato H, Raussens V, Ruysschaert JM, Narayanaswami V. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail. Biochemistry. 2006;45(36):10947–10956
  22. Todorich BM, Connor JR. Redox metals in Alzheimer's disease. Ann. N Y Acad. Sci. 2004;1012:171–178
  23. Uversky VN, Li J, Bower K, Fink AL. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. Neurotoxicology. 2002;23(4–5):527–536
  24. Weisman D, McKeith I. Dementia with Lewy bodies. Semin. Neurol. 2007;27(1):42–47
  25. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35

PII: S0197-4580(07)00419-8

doi: 10.1016/j.neurobiolaging.2007.10.018

Neurobiology of Aging
Volume 30, Issue 8 , Pages 1265-1271 , August 2009

Article Tools

* Image Usage & Resolution